The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis
Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-05-01
|
Series: | İstanbul Medical Journal |
Subjects: | |
Online Access: |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289
|
id |
doaj-44f229b8ae8a4990a6b6df0d2521a752 |
---|---|
record_format |
Article |
spelling |
doaj-44f229b8ae8a4990a6b6df0d2521a7522021-04-28T07:14:15ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2021-05-0122216116710.4274/imj.galenos.2021.8997213049054The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and PrognosisFettah Eren0Ayşegül Demir1Güllü Eren2 University of Health Sciences Turkey, Konya Training and Research Hospital, Clinic of Neurology, Konya, Turkey University of Health Sciences Turkey, Konya Training and Research Hospital, Clinic of Neurology, Konya, Turkey Necmettin Erbakan University, Meram Faculty of Medicine, Department of Public Health, Konya, Turkey Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate the value of the PLR and its relationship with mortality, cerebral hemorrhagic transformation, and short-term prognosis in patients with stroke treated with intravenous thrombolysis.Methods:Two hundred fifty stroke patients treated with intravenous thrombolysis were included in the study. Initial symptoms, comorbidities, and localization of cerebral ischemia were recorded. Disability was scored on the National Institutes of Health (NIH) stroke scale. At the 24th and 72nd hours after treatment, hemorrhagic transformation was evaluated by brain computed tomography. The in-hospital mortality rate was calculated. Patients were divided into groups according to the difference in the NIH stroke scale (between admission and discharge). Serum platelet and lymphocyte levels and PLR values were determined.Results:There were 128 (51.2%) female and 122 (48.8%) male patients included in the study. Their mean age was 71.88±12.36 years. The lymphocyte count was low and the PLR was high in patients with a high level of initial disability (p<0.01). The lymphocyte count was higher in patients with clinical improvement (p=0.023). The lymphocyte count was lower and the PLR was higher in patients who died (p<0.01). The platelet level was lower in patients with hemorrhagic transformation (p=0.024). The lymphocyte level and PLR were similar in the hemorrhagic transformation groups (p=0.156, p=0.675).Conclusion:In this study, it was determined that mortality is related to the PLR, and hemorrhagic transformation is related to platelet levels in patients with ischemic stroke treated with intravenous thrombolysis. http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289 ischemic strokeintravenous thrombolysisplatelet/ lymphocyte ratio |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Fettah Eren Ayşegül Demir Güllü Eren |
spellingShingle |
Fettah Eren Ayşegül Demir Güllü Eren The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis İstanbul Medical Journal ischemic stroke intravenous thrombolysis platelet/ lymphocyte ratio |
author_facet |
Fettah Eren Ayşegül Demir Güllü Eren |
author_sort |
Fettah Eren |
title |
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis |
title_short |
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis |
title_full |
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis |
title_fullStr |
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis |
title_full_unstemmed |
The Platelet/Lymphocyte Ratio in Patients with Ischemic Stroke Treated with Intravenous Thrombolysis and Its Relationship with Mortality, Disability, and Prognosis |
title_sort |
platelet/lymphocyte ratio in patients with ischemic stroke treated with intravenous thrombolysis and its relationship with mortality, disability, and prognosis |
publisher |
Galenos Yayinevi |
series |
İstanbul Medical Journal |
issn |
2619-9793 2148-094X |
publishDate |
2021-05-01 |
description |
Introduction:The platelet/lymphocyte ratio (PLR) has been studied frequently to determine the prognosis of cardiovascular diseases, chronic inflammatory diseases, and malignancies. Particularly, the PLR is an indicator of systemic inflammation and atherosclerosis. In this study, we aimed to evaluate the value of the PLR and its relationship with mortality, cerebral hemorrhagic transformation, and short-term prognosis in patients with stroke treated with intravenous thrombolysis.Methods:Two hundred fifty stroke patients treated with intravenous thrombolysis were included in the study. Initial symptoms, comorbidities, and localization of cerebral ischemia were recorded. Disability was scored on the National Institutes of Health (NIH) stroke scale. At the 24th and 72nd hours after treatment, hemorrhagic transformation was evaluated by brain computed tomography. The in-hospital mortality rate was calculated. Patients were divided into groups according to the difference in the NIH stroke scale (between admission and discharge). Serum platelet and lymphocyte levels and PLR values were determined.Results:There were 128 (51.2%) female and 122 (48.8%) male patients included in the study. Their mean age was 71.88±12.36 years. The lymphocyte count was low and the PLR was high in patients with a high level of initial disability (p<0.01). The lymphocyte count was higher in patients with clinical improvement (p=0.023). The lymphocyte count was lower and the PLR was higher in patients who died (p<0.01). The platelet level was lower in patients with hemorrhagic transformation (p=0.024). The lymphocyte level and PLR were similar in the hemorrhagic transformation groups (p=0.156, p=0.675).Conclusion:In this study, it was determined that mortality is related to the PLR, and hemorrhagic transformation is related to platelet levels in patients with ischemic stroke treated with intravenous thrombolysis. |
topic |
ischemic stroke intravenous thrombolysis platelet/ lymphocyte ratio |
url |
http://istanbulmedicaljournal.org/archives/archive-detail/article-preview/the-platelet-lymphocyte-ratio-in-patients-with-sch/47289
|
work_keys_str_mv |
AT fettaheren theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis AT ayseguldemir theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis AT gullueren theplateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis AT fettaheren plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis AT ayseguldemir plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis AT gullueren plateletlymphocyteratioinpatientswithischemicstroketreatedwithintravenousthrombolysisanditsrelationshipwithmortalitydisabilityandprognosis |
_version_ |
1721503892981678080 |